Per dialysis treatment funding and facility/network staff ratio by ESRD Network. Per dialysis treatment funding and facility/network staff ratio by ESRD.

Slides:

Advertisements

Similar presentations

Advertisements

Equivalent Ratios.

December 31st point prevalent counts by modality figure 3.1

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.

Measure Baseline 1 year p Coronary calcium scores

Nursing Home Staff Hours Per Patient Day

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

Survival advantage in Asian American end-stage renal disease patients1

Volume 78, Pages S33-S36 (August 2010)

Volume 70, Issue 12, Pages (December 2006)

Volume 76, Issue 3, Pages (August 2009)

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.

PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:

The global challenge of chronic kidney disease

Lynda Anne Szczech, Ira L. Lazar Kidney International

Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.

Sample timeline for disaster preparation and response.

Volume 57, Issue 2, Pages (October 2000)

(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E

Seven-year cumulative incidence of ESRD according to baseline creatinine clearance (Ccr) and result of urine test for proteinuria (19). Seven-year cumulative.

Mean (SD) weekly hemoglobin level (g/dl) and mean (SD) weekly epoetin dose by body weight (U/kg per week) were similar between epoetin alfa-epbx and epoetin.

Mean and median systolic and diastolic BPs after dialysis were unchanged over time and similar between epoetin alfa-epbx and epoetin alfa. Mean and median.

Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1 William M.

Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end.

Suggested treatment algorithm for resistant lupus nephritis

Ionized-to-total magnesium (Mg) and calcium (Ca) ratios are lower in patients on hemodialysis than those in patients not on dialysis. Ionized-to-total.

Ratio of actual to expected rise in sodium as calculated using the Adrogué-Madias formula. Ratio of actual to expected rise in sodium as calculated using.

Mean plasma concentrations of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis (duration depicted by box.

Dialyzer clearance of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis. Dialyzer clearance of ampicillin/sulbactam.

Ca2+ infusion rates during all three protocol versions.

(A) Distribution of CsA nephrotoxicity lesions according to antihypertensive treatment and CsA C2 levels. (A) Distribution of CsA nephrotoxicity lesions.

Response to cyclosporin A (CsA) treatment and renal outcome in patients with either nongenetic or genetic disease. Response to cyclosporin A (CsA) treatment.

Potential links between the immune dysfunction in uremia, inflammation, infection, and increased risk of atherosclerosis and cardiovascular disease. Potential.

Six-month change in proteinuria predicts risk for ESRD

Distribution of vascular access type (2002–2011) among countries with stable or decreasing catheter burden over time. Distribution of vascular access type.

Stephen Pastan, J. Michael Soucie, William M. McClellan

Risk for chronic kidney disease (CKD) among Olmsted County, MN, stone formers and control subjects. Risk for chronic kidney disease (CKD) among Olmsted.

Forest plot of adjusted incidence rate ratio for the primary outcome of rt-PA use for catheter malfunction, and secondary outcomes of bacteremia and catheter.

Mortality caused by cardiovascular disease (A) and sepsis (B) of patients with end-stage renal disease (ESRD) treated by dialysis compared with the general.

Cumulative mortality risk in patients with 48-h blood urea nitrogen (BUN) levels of ≥8 mg/dl or

We identified 200 Android and 178 iOS apps using 4 search terms and narrowed this to 12 Android apps, 11 iOS apps, and 5 dual-platform apps after applying.

Comparison of Medicare reimbursement to a nephrology practice on an annual per-patient basis for care of a patient on dialysis (at two different frequencies.

Relationship between excess fluid, as determined by the difference between measured and estimated body water, and plasma albumin (R = −0.40, P = 0.011).

Gentamicin plasma and peritoneal dialysate concentrations in peritoneal dialysis patients with peritonitis. Gentamicin plasma and peritoneal dialysate.

Distribution of percent consistent facility aspirin use.

New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.

Aliskiren, the orally effective renin inhibitor, provides antihypertensive efficacy at least equivalent to the ARB irbesartan in patients with hypertension.

Causal diagrams that represent three possible relationships between smoking, ESRD, and albumin-to-creatinine ratio (ACR) in the Study of Heart and Renal.

A total of 150 dialysis patients washed out of previous antihypertensive therapy (Pretreatment) and underwent periodic evaluation of aortic PWV (line indicating.

Effect of intervention differed across racial and socioeconomic groups

As the patient nears the end of life (dashed arrow), there is an increasing focus on symptom control and patient goals of care and a shift in the approach.

Attributable risk for disorders of mineral metabolism.

Dosage-response gradient for colorectal cancer according to serum 25-hydroxyvitamin D [25(OH)D] concentration of five studies combined. Dosage-response.

Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.

Incident cases of ESRD secondary to heroin-associated nephropathy, membranoproliferative glomerulonephritis type 1, HIV infection, and focal segmental.

Survival among hemodialysis patients by geographic region in DOPPS 3 (2005–2008), with and without adjustments for patient mix differences. Survival among.

Prevalence of primary aldosteronism in patients according to Sixth Joint National Committee (JNC VI) stages of severity of hypertension (stage 1, 140 to.

Pancreas transplantation is performed at transplant centers within 56 of the 58 federally designated donor service areas (DSAs). Pancreas transplantation.

Study protocol. Study protocol. All participants were studied on four occasions: Twice before and twice after an 8-wk treatment period on low-dosage, low.

Mean number of dialysis sessions per patient for which intradialytic hypotension–related nursing interventions were required during the first 2 wk and.

Forest plot shows the risk ratio of masked hypertension (among clinic normotension) to white-coat hypertension (among clinic hypertension). Forest plot.

Plateau 13C-ketoisocaproic acid (KIC) enrichment during whole-body protein turnover (WBPT) study. 13C-KIC values (mean ± SD) in 12 patients in moles percent.

Distribution of facility mean treatment time, by DOPPS region and phase. Distribution of facility mean treatment time, by DOPPS region and phase. Restricted.

Presentation transcript:

Per dialysis treatment funding and facility/network staff ratio by ESRD Network. Per dialysis treatment funding and facility/network staff ratio by ESRD Network. (A) Per dialysis treatment funding by ESRD Network. Data represent the December 31, 2010, dialysis population and calendar year 2011 network funding (ESRD Network Program, unpublished data). (B) Facility/network staff ratio by ESRD Network. Data represent facilities as of December 31, 2010 and full time equivalent staff funded in the 2011–2012 network contract (ESRD Network Program, unpublished data). Jay B. Wish, and Klemens B. Meyer CJASN 2012;7:1907-1914 ©2012 by American Society of Nephrology